Macular degeneration: Nursing

Last updated: January 28, 2022

Macular degeneration: Nursing

Watch later

Watch later

Cholinomimetics: Direct agonists
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Osteoporosis: Nursing
Osteomyelitis: Nursing
Paget disease of bone: Nursing
Cerebral palsy: Nursing
Down syndrome (Trisomy 21)
Encephalitis: Nursing
Headaches: Pathology review
Meningitis: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Erysipelas and cellulitis: Nursing
Antibiotics - Penicillins: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Cutaneous fungal infections: Nursing
Antibiotics - Cephalosporins: Nursing pharmacology
Antibiotics - Macrolides: Nursing pharmacology
Antivirals for influenza: Nursing pharmacology
Antivirals for herpesviruses: Nursing pharmacology
Antivirals for hepatitis B and C: Nursing pharmacology
Antibiotics - Fluoroquinolones: Nursing pharmacology
Antibiotics - Tetracyclines and glycylcyclines: Nursing pharmacology
Antidepressants - Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs): Nursing pharmacology
Glaucoma: Nursing process (ADPIE)
Antidepressants - SSRIs and SNRIs: Nursing pharmacology
Gout: Nursing process (ADPIE)
Antiretrovirals for HIV/AIDS - CCR5 antagonists, fusion inhibitors, and attachment inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Integrase strand transfer inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Protease inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - NRTIs and NNRTIs: Nursing pharmacology
Cataracts: Nursing
Detached retina: Nursing
Macular degeneration: Nursing
Meniere disease: Nursing
Growth and development - Infant: Nursing
Otitis media: Nursing
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Diabetes mellitus (DM): Nursing process (ADPIE)
Anatomy and physiology of the eye
Physical assessment - Eyes: Nursing
Conjunctivitis: Nursing process (ADPIE)
Eye conditions: Inflammation, infections and trauma: Pathology review
Anatomy of the eye
Pediatric psychosocial needs during illness and hospitalization: Nursing
Hearing impairment and otosclerosis: Nursing
Growth and development theories: Nursing
Growth and development - Preschool-age: Nursing
Growth and development - Toddler: Nursing
Growth and development - School-age: Nursing
Growth and development - Adolescent: Nursing
Antibiotics - Carbapenems and monobactams: Nursing pharmacology
Antibiotics - Trimethoprim and sulfonamides: Nursing pharmacology
Antibiotics - Beta lactam and beta lactamase inhibitor combinations: Nursing pharmacology
Antibiotics - Aminoglycosides: Nursing pharmacology
Medications for respiratory syncytial virus (RSV): Nursing pharmacology
Mycobacterium tuberculosis (Tuberculosis)
Hypersensitivity reactions - Type II: Nursing
Lyme disease: Nursing process (ADPIE)
Systemic lupus erythematosus (SLE): Nursing
Preoperative care: Nursing
Postoperative care: Nursing
Chest tube care: Nursing
Analgesics for obstetrics: Nursing pharmacology
Analgesics: Nursing pharmacology
Acne: Nursing
Burn injury: Nursing
Impetigo: Nursing
Insect stings and bites: Nursing
Psoriasis: Nursing
Herpes zoster: Nursing
Urticaria: Nursing
Pressure injury: Nursing process (ADPIE)
Cholinergic therapy (GU): Nursing pharmacology
Physical assessment - Skin, hair, and nails: Nursing
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Narcolepsy (NORD)
Autism spectrum disorder (ASD): Nursing
Insomnia
Hemorrhagic stroke - Intracranial hemorrhage (ICH) and subarachnoid hemorrhage (SAH): Nursing
Body fluid compartments
Anemia - Macrocytic: Nursing
Anemia - Iron-deficiency: Nursing
Vitamin D
Vitamin B12 deficiency
Role of Vitamin K in coagulation
Folate (Vitamin B9) deficiency
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Hypertension: Nursing process (ADPIE)
Hypersensitivity reactions - Type I: Nursing
Hypersensitivity reactions - Type III: Nursing
Hypersensitivity reactions - Type IV: Nursing
Immune response - Adaptive: Nursing
Immune response - Innate: Nursing
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS): Nursing
Antiglaucoma medications: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Insulin: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Antihistamines: Nursing pharmacology
Antacids: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Physiology of pain: Nursing

Notes

MACULAR DEGENERATION

KEY POINTS
NOTES
DEFINITION
  • Degeneration of the macula
    • Dry/nonexudative
    • Wet/exudative

PHYSIOLOGY
  • Layers of the eye
    • Fibrous outer layer
      • Cornea and sclera
    • Middle vascular layer
      • Iris, pupil, ciliary body, and choroid
    • Inner neural layer
      • Retina
        • Macula

CAUSES AND RISK FACTORS
  • Causes
    • Unknown
  • Modifiable risk factors
    • Smoking
    • Diabetes
    • Hypertension
    • Hyperlipidemia
  • Non-modifiable
    • Aging
    • Family history

PATHOLOGY
  • Dry 
    • Develops slowly
    • Drusen build up between choroid and retinal pigment epithelium
  • Wet 
    • Develops rapidly
    • Abnormal neovascularization

SIGNS AND SYMPTOMS
  • Blurry and distorted vision
  • Poor night vision
  • Scotomas
  • Central vision loss
  • Legally blind with intact peripheral vision

DIAGNOSIS
  • History
  • Physical assessment
  • Ophthalmoscopy
  • Slit lamp biomicroscopy
  • Amsler grid test
  • Optical coherence tomography
  • Fluorescein angiography

TREATMENT
  • Dry
    • Healthy diet
    • Multivitamin and antioxidant supplements
  • Wet macular degeneration
    • Intraocular injection of anti-VEGF medications
    • Ocular photodynamic therapy
    • Verteporfin
    • Laser photocoagulation therapy

MANAGEMENT OF CARE
  • Goals of care
    • Promote independence and safety
    • Support with psychological challenges
  • Assessment
  • Review results of visual acuity and diagnostic tests
  • Ask how vision impacts activities
  • Help to coordinate care and resources
  • Assess coping
  • Allow patient to express feelings
  • Report to HCP
    • Signs of depression or suicidal ideation

PATIENT AND FAMILY EDUCATION
  • Explain condition, plan of care, and how to safely self-administer medications
  • Treatment with VEGF inhibitors
  • Lifestyle choices
  • Smoking cessation
  • Sunglasses
  • Healthy diet
  • Environmental modifications
  • Home free from hazards
  • How to use Amsler grid
  • Monitor their own visual changes
  • Notify HCP
    • Changes to vision
    • New visual problems

Transcript

Watch video only

Macular degeneration is an eye condition in which the part of the retina that is responsible for clear vision, called the macula, degenerates. This causes blurred or reduced central vision, and is typically related to aging. There are two main types of macular degeneration: dry or nonexudative, which is the most common one; and wet or exudative.

Okay, but first, a bit of physiology. If we zoom into the wall of the eye, it is made up of three major layers. There's a fibrous outer layer, which contains the cornea and sclera, and helps shield excess light. The middle vascular layer is called the uvea and consists of the iris, pupil, ciliary body, and choroid. Finally, the neural layer consists of the retina, with its own outer pigmented layer, and an inner neural layer that’s composed of photoreceptor cells, called rods and cones, which convert light into neural signals that travel via the optic nerve to the brain for visual processing.

Now, there’s an oval spot in the middle of the posterior retina, called the macula, which contains the highest concentration of cones and is the part of the retina that offers the highest visual acuity.

Alright, now, even though the exact cause of macular degeneration is still unknown, several risk factors have been identified. Modifiable risk factors include smoking, diabetes, hypertension, and hyperlipidemia, whereas non-modifiable risk factors include aging and a family history of macular degeneration.

Now, let’s look at the pathology of macular degeneration. Dry macular degeneration typically develops slowly over time and is characterized by yellowish extracellular deposits of waste materials, known as drusen, that build up between the choroid and the retinal pigment epithelium. On the other hand, in wet macular degeneration, which develops rapidly, there is abnormal neovascularization, meaning that abnormal blood vessels grow from the choroid behind the retina and can leak intravascular fluid or blood.

In terms of signs and symptoms, clients with macular degeneration typically present with blurry and distorted vision, poor night vision, as well as scotomas or missing areas of vision. Eventually, clients can develop central vision loss and become legally blind, even though their peripheral vision remains intact.

The diagnosis of macular degeneration starts with the client’s history and physical assessment, followed by ophthalmoscopy and slit lamp biomicroscopy to examine the retina. In dry macular degeneration, this shows the drusen, whereas in wet macular degeneration, retinal bleeding, and edema can be seen.

Other diagnostic tests include the Amsler grid test, which is basically a grid that has a small central dot and might help better define the areas of the visual field that are missing. In addition, optical coherence tomography can be used to take cross-section pictures of the retina. Fluorescein angiography can be used to show the newly formed abnormal blood vessels in wet macular degeneration.

Now, treatment varies depending on the type of macular degeneration. For dry macular degeneration there’s no cure, so treatment focuses on slowing down vision loss. Maintaining a healthy diet, as well as multivitamin and antioxidant supplements has been shown to help. On the other hand, wet macular degeneration can be treated with intraocular injection of anti-VEGF medications like ranibizumab, that inhibit the formation of new blood vessels, or ocular photodynamic therapy along with a light-sensitive drug called verteporfin. Finally, laser photocoagulation therapy can be also done to seal off the leaking blood vessels.

Alright, let’s take a look at the nursing care you will provide for a client with macular degeneration. Priority nursing goals include promoting independence and safety despite decreased visual acuity, and to support the client with the psychological challenges that come with progressive vision loss.